|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1988-12-6
|
|
pubmed:abstractText |
Expression of virulence factors by Bordetella pertussis is altered by environmental signals (antigenic modulation) and is dependent on an activator encoded by a gene called vir. We have used TnphoA (Tn5 IS50L::phoA) gene fusions to define two sets of genes whose expression is either activated (vag loci) or repressed (vrg loci) by modulation signals. Both groups of genes appear to be regulated by the vir gene product in that, in the absence of modulators, null mutations in vir lead to the repression of vag gene fusions and derepression of vrg gene fusions. Mutants of B. pertussis were isolated that constitutively express virulence factors in the presence of the modulator MgSO4, nicotinic acid, or low incubation temperature. We designate the gene that carries such mutations mod (modulation) and have characterized one (mod-1) of these mod constitutive mutations. A method was developed for the insertional inactivation of the vir gene by using the integration of a suicide replicon. Inactivation of the vir gene in the mod-1 mutant, followed by transcomplementation with the cloned wild-type vir gene, gives the Mod-1 constitutive phenotype, showing that the mod-1 mutation defines a gene distinct from vir. The gene carrying the mod-1 mutation is linked to vir and was cloned on a recombinant cosmid (pLAF-C1) which transcomplements the vir-1::Tn5 mutation in B. pertussis 347. Introduction of pLAF-C1 into vir mutant and vir+ B. pertussis strains also gives the Mod-1 constitutive phenotype, indicating that mod-1 is a dominant allele. These data suggest that the mod gene product could have sensory functions for the environmental signals that affect the expression of vir-regulated genes of B. pertussis. The mod constitutive strains and plasmids described here also have applications in pertussis vaccine development.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-1094240,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-13296323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-14413273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-2836362,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-2877614,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-2883655,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-2898470,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-2999794,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-3002984,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-3007938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-3308853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-3535654,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-3731272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-3802195,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-5432063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6218886,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6273564,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6279517,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6290332,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6305841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6311749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6317569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2903140-6372090
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0021-9193
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
170
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5059-66
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2903140-Bordetella pertussis,
pubmed-meshheading:2903140-Cloning, Molecular,
pubmed-meshheading:2903140-Conjugation, Genetic,
pubmed-meshheading:2903140-Cosmids,
pubmed-meshheading:2903140-DNA Transposable Elements,
pubmed-meshheading:2903140-Escherichia coli,
pubmed-meshheading:2903140-Genes, Bacterial,
pubmed-meshheading:2903140-Genes, Regulator,
pubmed-meshheading:2903140-Mutation,
pubmed-meshheading:2903140-Plasmids,
pubmed-meshheading:2903140-Virulence
|
|
pubmed:year |
1988
|
|
pubmed:articleTitle |
Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis.
|
|
pubmed:affiliation |
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
